Opthea Announces Publication in Diabetic Macular Edema

Phase 1b clinical data underpins sozinibercept's potential as a novel, first-in-class VEGF-C/D ‘trap' to improve visual and anatomic outcomes in DME Published in peer-reviewed journal Translational Vision Science & Technology and included in the Anti-VEGF Special Journal Issue of ARVO DME program to be advanced after wet AMD topline data readout anticipated for COAST in early CY Q2 2025 and ShORe in mid-2025 MELBOURNE, Australia and PRINCETON, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:O ...